Qtick
Sign in
‹ Back to the callNUVLNuvalent Inc$123.960.00%
Deep dive · NGM: NUVL

Nuvalent Inc stock analysis

Everything behind the call on Nuvalent Inc. 6 sections, ordered the way risk stacks up: survival first, quality and price in the middle, context last. The Beacon gives you the read. This is where you check the work.

The five reads
Why the reads disagreeread this before the sections

1 factors lean up and 3 lean down and one side is clearly ahead. The net lands at -5 over 30d, a leaning reading on a dispersion of 0.00.

Leans up · and why
sentiment vote up. 0 of 4 independent evidence families agree.
Leans down · and why
earnings, quality / value, insider flow vote down. 4 of 4 families lean the other way.
What it changes
Size, not direction. dealers are long gamma, so their hedging absorbs moves rather than amplifying them.
Global tape
No overseas listings — NUVL trades on its home exchange only.
The bottom linestart here
Wall Street rating
Hold
Across 18 covering firms
0% buy · 100% hold · 0% sell
Valuation
-30.9× forward
Against consensus earnings
FCF yield -2.81%
Dividend
0.00%
A rounding error against cash — this is a capital-gains position
Risk flags
1 critical
5 checks run, 1 clear
worst drawdown 0%
New to this? Every metric carries a plain-English read beside it, and an ⓘ next to a label opens the definition. Anything unfamiliar is also defined at the foot of the page under Glossary.
In one paragraphwhat the company actually does125 chars

Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

NGM · USDBiotechnology
$123.960.00 · 0.00%CLOSED · vol 3.09M
52-week range↑ 74% off low · ↓ 0.0% off high
$71.13now $123.96$123.99
Quote Jul 14, 2026 · 4:00 PM ET
Tape 2026-07-21
01Ratios · Jun 22, 2026SOLVENT · 1 FLAGGED

Survival & solvency

Altman-Z of 34.8 against a 3.0 safe threshold, and 1 of 5 forensic checks clear.

↳ Plain EnglishBefore anything else: can this company pay its bills? These blocks check the balance sheet, whether your slice of ownership is being diluted, and whether the accounting looks honest.
Bankruptcy risk (Altman-Z)
34.75SAFE ZONE
Distress<1.8
Grey1.8–3.0
Safe>3.0
Profitability, leverage and liquidity combined into one number. Above 3.0 is the safe band.
Balance sheetJun 22, 2026
Piotroski F-scoreCRITICAL
F 1/7
Piotroski F-score 1 of 7. Nine pass/fail tests covering profitability, leverage and operating efficiency; seven or more is strong.
Solvency and liquidity ratios
Current ratioshort-term assets against short-term bills15.27×healthy >2
Your ownership stake
Share-count growth vs peersHIGH DILUTION
96th pctile
Where this name's share-count growth ranks among peers. Lower is less dilutive.
Diluted vs basic share gapTHIN OVERHANG
0.00%
Options and awards already granted, expressed as the gap between the diluted and basic counts.
Accounting forensicsSEC filings
Red-flag x-rayGRADE D
50 / 100
1 critical · 1 watch · 1 clear of 3 scored tests
1 of 5 checks clear
Red-flag x-ray · every check, passes included
CheckStatusValueWhat it looks for
Bankruptcy distressCLEARZ 34.82Altman-Z in the Safe · fundamentals
Earnings manipulationNAn/aBeneish-M not available · fundamentals
LeverageNAn/aLong-term debt / equity not available · fundamentals
Profitability qualityCRITICALF 1/7Piotroski F-score 1 of 7 · fundamentals
Filing forensicsWATCH2 flags2 filing red flags on the latest 10-K · forensic
5 checks, 1 clear and 1 watch and 1 critical. The passes are shown because a score built from five checks means something different from one built from three.
02Refreshed · Sep 27, 2026POOR · 18/100

Business quality

-34% return on equity.

↳ Plain EnglishMargins tell you how much of each sales dollar the company keeps. Return on capital tells you whether reinvesting that money creates value. Both are read against what the filings support, not against a target.
Quality score
18 / 100POOR
Profitability, growth and balance strength scored separately, then blended.
ProfitabilityRefreshed · Sep 27, 2026
Return on equityPER $1 OF EQUITY
-34.1%
Annual return on each dollar of shareholder equity.
Asset growth vs peersIN LINE
74th pctile
The balance sheet grew +24% on the year. Fast asset growth is usually a ramp; occasionally it is the start of an inventory problem.
As of · Sep 20, 2026
Revenue (TTM)TRAILING
$0
Trailing twelve-month revenue from the latest filings.
Growth & relative strength
Data unavailableNot enough price and filing history to compute growth or relative strength for this name.
Around earningsMay 7, 2026
P(beat next quarter)COHORT BASE RATE
39%
survivor-tilted universe (currently-listed names; large-cap-skewed coverage)
cohort n=20,787 · this name's own n=8 · since 2000
Beat rate · this nameBEAT ≤2 OF THE LAST 8
0 of 8
Its own record against consensus. 8 prints is a small sample, which is why the cohort rate above carries the probability.
n=8 measured prints
Beat and still fellSHARE OF ALL PRINTS
10%
Of every report in the window, this share both beat consensus and closed lower on the day.
n=20 prints — a joint share of every print, not P(fell | beat); the conditional needs more measured beats
Rose after a missP(ROSE | MISS)
43%
The mirror of the line above, over its own denominator.
n=14 misses
Typical earnings moveMEDIAN ABSOLUTE
±3.2%
Unsigned magnitudes from its own prints. Direction is not part of this read.
n=20 prints · p90 ±5.7% · worst 12.3% (2022-08-10)
Reaction: beat vs missData unavailableThe beat-versus-miss reaction gap is not computed for this name — undetermined — needs ≥12 measured beats.
Dividends & income
Data unavailableThis company does not pay a dividend. There is no yield, payout ratio or ex-dividend date to show, and the return case rests entirely on capital gains.
Signal
Not an income position.

No dividend is declared, so nothing here contributes to total return except the price. That is a fact about the security, not a criticism of it.

Inventory ledger
Data unavailableNo inventory detail is tagged in this company's filings. The ledger needs the XBRL inventory components, which a business without physical goods does not report.
Segments & geography
Data unavailableRevenue by segment and region is not on file for this name, so product and geographic concentration are not shown.
Pattern reliability · platform-wide cohortSnapshot · Sep 27, 2026
Uptrend · leans bullish
HorizonHigherMedianObservations
10d47%0.0%1,132,432
21d47%-0.1%531,932
63d48%-0.7%170,248
slope +0.25 over 40 bars
Dragonfly doji · leans bullish
HorizonHigherMedianObservations
10d36%0.0%507,560
21d40%0.0%237,486
63d44%0.0%73,638
long lower shadow, open=close near high
Tweezer top · leans bearish
HorizonHigherMedianObservations
10d46%0.0%324,295
21d47%0.0%152,024
63d50%0.0%48,500
matching highs
Double top · leans bearish
HorizonHigherMedianObservations
10d50%0.0%1,216,877
21d51%+0.1%572,733
63d52%+0.3%181,607
two peaks ≈ equal — reversal if neckline breaks
Triple top · leans bearish
HorizonHigherMedianObservations
10d50%0.0%975,500
21d52%+0.2%458,215
63d54%+0.5%144,909
three peaks ≈ equal
Ascending triangle · leans bullish
HorizonHigherMedianObservations
10d50%0.0%646,584
21d51%+0.1%303,544
63d53%+0.5%96,103
flat resistance, rising support
Cup and handle · leans bullish
HorizonHigherMedianObservations
10d46%-0.2%701,064
21d47%-0.4%328,275
63d47%-1.4%104,377
U-base + small handle pullback
52w breakout · leans bullish
HorizonHigherMedianObservations
10d43%0.0%195,888
21d46%0.0%91,765
63d52%+0.2%28,677
at/near 52-week high
Near resistance · leans bearish
HorizonHigherMedianObservations
10d51%+0.1%530,198
21d52%+0.2%248,435
63d54%+0.4%78,078
testing recent resistance
Near support · leans bullish
HorizonHigherMedianObservations
10d51%+0.1%536,115
21d53%+0.2%251,312
63d54%+0.4%78,900
testing recent support
Bollinger squeeze
HorizonHigherMedianObservations
10d43%0.0%764,373
21d45%0.0%357,385
63d47%0.0%112,620
bands at a multi-month tight — breakout pending
03-30.9× FORWARD

Price & timing

Price $123.96, -30.9× forward earnings, RSI 60, and dealers long gamma.

↳ Plain EnglishA multiple is what the market charges for a dollar of this company's earnings, cash or revenue; the trend and the options tape say what the price is doing around it. Together they are the timing picture, not the quality one.
Momentum (RSI-14)
60WARM
030 oversold70 hot100
Where momentum sits on a 0–100 scale. Above 70 is overbought, below 30 oversold; the middle says the move has room either way.
The setup right now
Price · 504 sessions2024-07-17 → 2026-07-21
$51$71$90$109$128CALL WALL $115PUT WALL $120$123.96
price50-day200-daylevel
How to read this
Up 0.00% on the session.

Follow the solid line: each point is a session close. Compare it to the 50-day average — while price stays above it the short-term trend is up, and a drop below is the first structural warning.

The dashed levels are the strikes the options chain is most committed to. They are the same numbers the gamma block states; nothing here is drawn that no section derives.

Market cap$9.79B
Day range$123.95 – $123.99
Above 52-week low+74%
Worst drawdown0.0%
MACDABOVE SIGNAL
+2.39
The short-term trend against its own signal line. The sign is the read; the size is not a target.
Pivots (classic)R1 $124 · S1 $124
$123.96
The last settled session's range projected forward. Reference levels, not predictions — after a big gap they can sit on the wrong side of the price until the next close.
DeMark countdownFLAT SETUP
0 of 9
Counts consecutive closes against the prior trend. A completed 9 often marks exhaustion.
2026-09-29 · in 2 daysJob Openings (JOLTS)A scheduled macro release. It moves this stock independently of anything the company does.
Setup & oddsNightly
Direction oddsnext 12m
50 / 50cohort n=13,076
Effectively a coin flip. A split this close is not an edge you can size on, whichever side is nominally ahead. These are the cohort's odds — comparable names over the window — not this stock's own history.
Pullback riskoverstretch read
In line1.00× segment rate · n=80,992
Historically, mid names in this tape state saw a ≥10% pullback within 63 trading days in 79% of cases (n=80,992).
Signal
The odds are a coin flip.

Historically, names tripping 1 validated red flag finished lower 12 months later in 50% of cases (n=13,076) — a survivor-biased floor, not a forecast.

Valuation
Multiples
Forward P/EAnalysts expect a loss over the next twelve months, so there are no earnings for the price to be a multiple of.Not meaningful
Trailing P/EThe company lost money over the trailing year, so there are no earnings for the price to be a multiple of.Not meaningful
Price / bookprice against the accounting value of the assets7.8×
FCF yieldfree cash flow per dollar of market value-2.81%
2 of the 2 priced multiples above sit in the richer half of its band. 2 are marked not meaningful because the figure they divide into is negative — shown as absent rather than as a low, cheap-looking number. Each priced multiple is read against this stock's own history where a five-year range is on file, so the question is whether today is dear for this name rather than for the market. The multiples are computed separately from the quote above and are not re-priced as it moves, so they can lag it.
Price horizon & timing
Data unavailableThis security is delisted, so there is no live tape to compose entry, target and stop against.
Gamma mapChain · Jul 31, 2026
Signal
Long gamma — moves get absorbed.

Dealers hedge against the move, which damps volatility around the current strikes. It makes the tape quieter without saying anything about which way it goes.

Dealer-hedging mechanics. Useful if you trade options; the takeaway above is what it means for the share price.
Options tapeLast snapshot before the 2026-08-21 expiry · Chain · Jul 31, 2026
Max pain-3.2%
$120.00
The strike where most open options would have expired worthless on the last snapshot. That expiry has passed; the next chain read replaces it.
Last snapshot before the 2026-08-21 expiry
Put / call ratio (OI)PUT-HEAVY
8.89
10% calls
90% puts
Open interest in puts against calls. Heavy call interest often caps how far price can run before expiry.
Put / call ratio (volume)TODAY'S FLOW
11.27
Today's traded flow rather than the standing position. It moves faster and means less.
Expected move (1-week)≈ $0.07
±0.1%
What the chain prices for the week. A range the market is charging for, not a forecast.
of the chain spot $123.96
Largest open interest · front expiry
StrikeTypeOpen interest
$120.00PUT731
$105.00PUT109
$115.00CALL30
$130.00CALL14
$135.00CALL10
$115.00PUT10
Large call interest above the price acts as a magnet and a ceiling; large put interest below is a floor of hedges. The biggest strike is the level the market is most committed to defending into the next expiry.
Open interest by strikeexpires 2026-08-21 (expired)CallsPutsMax pain $120.00
2
$170.00
01
$165.00
01
$160.00
01
$155.00
00
$140.00
010
$135.00
014
$130.00
04
$125.00
31
$120.00
73130
$115.00
103
$110.00
02
$105.00
1090
$100.00
01
$95.00
00
$90.00
07
$85.00
0
The shaded row is the strike nearest the price. Heavy call interest above acts as a ceiling; heavy put interest below is a floor of hedges.
↑ 52-week high$123.990.0%The highest print of the past year.Old highs draw profit-taking on the first attempt.
↑ Call wall$115.00-7.2%Heaviest call open interest on the front expiry.Acts as a ceiling into expiry; a close above usually needs a catalyst.
◇ Max pain$120.00-3.2%Where most open options expire worthless.Price often drifts toward it into the close of the expiry week.
↓ Put wall$120.00-3.2%Heaviest put open interest — a floor of hedges.Dealer buying tends to build as price approaches.
0413F quarterly · Form 4 dailyNET SIGNAL -5

Ownership & flow

Institutions hold 113%, short interest is 5.94% of float.

↳ Plain EnglishWho is buying and selling, and what they had to disclose. Institutions file 13F 45 days after quarter end, executives file Form 4 within two days, and Congress discloses under the STOCK Act with a 30–45 day legal lag. Every one of those is a look backwards.
Net signal
-5LEANING · 30d
Earnings -3
Quality / value -2
Insider flow -1
Sentiment +1
1 bull / 3 bear factors. The points sum to the net beside the label; nothing here is weighted after the fact.
The QTick signalNightly
Earnings4 QUARTERS · TIMING
-3
latest EPS missed by 6%
Insider flow120D · TIMING
-1
net insider selling ($2,844,014,333 across 75 sells) in 120d
Quality / valueTTM · CONTEXT
-2
weak Piotroski F-score (1/7)
Sentiment1–30D · TIMING
+1
7d sentiment elevated (83/100)
Signal
1 bull / 3 bear factors

Independent factors scored and netted to -5 over 30d, a leaning reading. 4 of 9 factors carried a direction; the others scored zero and do not vote. The signal describes where the data leans, not what to do about it.

Cross-category readSep 26, 2026
Signal
4 of 4 families lean down.

Descriptive only — a decorrelated read of where the evidence agrees and conflicts, not a forecast and not advice. Patterns are condition lists, not outcome predictions, and are not yet validated to the proof bar. Dispersion of 0.00 means the disagreement is real but not a split decision.

A check on whether independent evidence families agree, rather than a second score.
Wall Street18 covering firms
Consensus rating18 ANALYSTS
Hold
0% buy · 100% hold · 0% sell, as a share of the 18 covering firms.
Forward EPS estimateCONSENSUS
$-4.02
What the panel expects the company to earn per share.
next year · 10 analysts
Who owns it13F quarterly · Form 4 daily
Institutional ownershipINSTITUTIONALLY HELD
113.3%
The share held by 13F filers. It describes last quarter's positioning, not today's — filings land up to 45 days after quarter end.
Insider ownershipOFFICERS & DIRECTORS
2.8%
The share held by the people running the company.
Short interest (float)LIGHT
5.94%
The share of the tradable float sold short.
Free float67% OF SHARES
48.98M
Shares actually available to trade, excluding insider and restricted holdings.
Dollar volume (ADV)94th PCTILE
$288.82M/day
At this depth, position size is not a constraint for a retail account.
Borrow feeData unavailableWe do not license securities-lending data, so the annualized cost of borrowing shares to short is not something we can show. Short interest and days-to-cover above are the closest read we can source.
Insider filings · Form 4
InsiderTradeAmountPlanTraded
Flynn James E · Director, 10% owner, Director by DeputizationSellnot on file—15 Jul
Flynn James E · Director, 10% owner, Director by DeputizationSellnot on file—15 Jul
Flynn James E · Director, 10% owner, Director by DeputizationSell$1029.1M—15 Jul
Flynn James E · Director, 10% owner, Director by DeputizationSellnot on file—15 Jul
Flynn James E · Director, 10% owner, Director by DeputizationSellnot on file—15 Jul
Flynn James E · Director, 10% owner, Director by DeputizationSellnot on file—15 Jul
Executives must file within two business days. Sales on pre-set 10b5-1 plans are scheduled months ahead and carry little signal; tax withholding, exercises and awards are compensation mechanics, not trades; the open-market lines are the ones to read.
The story · news & sentimentRolling window
Why it moved on Sep 25, 2026NONE
flat
We don't have a fresh enough quote for NUVL to measure its move since the last close.
Matched · Sep 25, 2026
News tone · 7-day—
83 / 100
Headline polarity over the window, scored from news articles. Above 60 leans positive, below 40 negative. Colour, not a signal.
Newswire · 45 stories
WhenHeadlineSourceTone
MonNuvalent, Inc. (NUVL) Stock Analysis: Navigating the Biotech Landscape with a Clinical Focus - DirectorsTalk InterviewsDirectorsTalk Interviewsnot scored
Sep 14Nuvalent, Inc. (NUVL) Stock Analysis: Unlocking the Potential of Innovative Cancer Therapies - DirectorsTalk InterviewsDirectorsTalk Interviewsnot scored
Sep 7Nuvalent, Inc. (NUVL) Stock Analysis: What Investors Need to Know About This $9.81 Billion Biotech Player - DirectorsTalk InterviewsDirectorsTalk Interviewsnot scored
Aug 31Nuvalent, Inc. (NUVL) Stock Analysis: Exploring the Biotech’s Steady Path with a $9.81 Billion Market Cap - DirectorsTalk InterviewsDirectorsTalk Interviewsnot scored
Aug 24Nuvalent, Inc. (NUVL) Stock Analysis: Evaluating Growth Potential Amidst a Steady Market Position - DirectorsTalk InterviewsDirectorsTalk Interviewsnot scored
Aug 23Nuvalent (NUVL) Earnings Report: EPS Comes in Below Forecast in the Current Update; Investor Response: The Market Reaction Is Muted at the Close - Low Estimate Range - vinanet.vnvinanet.vnnot scored
Aug 23Nuvalent (NUVL) Earnings Report: EPS Comes in Below Forecast in the Current Update; Investor Response: The Market Reaction Is Muted at the Close - Earnings Revision Report - dars.gov.etdars.gov.etnot scored
Aug 21Nuvalent (NUVL) Results Review: EPS Does Not Reach the Reported Estimate in the Latest Reading; Latest Reaction: The Immediate Price Response Is Limited for the Current Session - Surprise Factor Analysis - dars.gov.etdars.gov.etnot scored
Coverage published around the move, newest first. Nothing here measures causation — only the why-it-moved card above is matched to the tape by timestamp.
Congress
Data unavailableNo congressional trades in this name have been disclosed under the STOCK Act. Lawmakers' disclosed trades cluster heavily in large caps, so an empty list is the usual state.
0510 graded calls

Risk & track record

a 0% worst drawdown, and 1 of 8 risk surfaces clear.

↳ Plain EnglishWhat owning it does to a portfolio, what the model votes against, and how often our own calls have been right. Every call is graded when it resolves, and the ones still open stay visible.
Max drawdown
0.0%WORST FALL
The deepest peak-to-trough fall in the measured window. Only hold a position you can watch do this.
What it does to a portfolio5-year window
What votes againstNightly
HighEarningslatest EPS missed by 6%4 quarters · -3
MedQuality / valueweak Piotroski F-score (1/7)TTM · -2
LowInsider flownet insider selling ($2,844,014,333 across 75 sells) in 120d120d · -1
Signal
3 of 9 factors vote against.

Ranked by the size of each factor's own point contribution to the net signal — these are the model's stated reasons, not a written bear case. Each one is scored from the source named beside it.

Failure modes · by company type
Data unavailableFailure modes are routed per company type, and only the bank-run and crypto-treasury rulebooks are validated so far. This name routes as growth, so there is no cohort-specific checklist to run. A generic list would read as analysis without being any.
The risk case · why not to buy8 surfaces · nightly
Avoid score6-month distress
0.6%0.1× its cohort · most-traded mega-caps
Observational 6-month large-drawdown risk ranking — not a forecast, not alpha. Historical distress rate for this most-traded mega-caps segment: 9.3%. This name reads 0.1× that base rate.
LowDistress screenThe distress model did not score this name in the latest run, so this surface is unmeasured rather than clear.Not scored
LowPosition sizeThe sizing model has not covered this name, so no defensible cap is published for it.Not scored
LowLottery-ticket behaviourNot scored for this name.Not scored
HighCash runwayAbout 2.0 quarters of cash at current burn ($160M cash against $313M a year of burn) - names in this bucket: 26.8% catastrophe rate within a year.Solvency
LowPost-earnings driftNo measured earnings reaction on file, so the drift surface is unmeasured.Not scored
LowDividend riskNot scored for this name.Not scored
LowRestatement historyFiling history is not deep enough to check for restatements.Not scored
LowCrowded shortNot in a warn state: the crowded-short model only publishes when short interest and thin liquidity coincide, and neither condition is met here.Not scored
Signal
1 of 8 surfaces clear.

8 surfaces checked, 1 clear. Each row states which surface it is and what it measured; a surface that could not be scored says so rather than counting as clear.

Who should skip it
Skip it if any of these is you
You want income
A 0.00% yield is a rounding error against cash. This is a capital-gains position.
Our track record10 resolved
Track recordBUILDING IN THE OPEN
25 logged
25 calls logged on this name, 10 resolved so far. Calls are logged the moment they are made, so the open ones are public before anyone knows how they turn out, and a hit-rate is not published until enough of them resolve.
10 resolved · 15 open
Calls on NUVLTHIS NAME
25
This name's own call count. Too few have resolved to publish a rate over them, so none is shown rather than a rate over 10.
0610-K disclosed linksBIOTECHNOLOGY

The wider context

5 mapped peers, 3 connections.

↳ Plain EnglishCompanies do not trade alone. This is the peer set, the supply chain that has to deliver, and the macro variables that move the stock regardless of company news.
Rate sensitivity
-69.2% per +1ppINSUFFICIENT
This is the SECTOR prior, not a measurement of this name — the regression did not clear its own bar. The verdict beside it (neutral) comes from the prior too, so the two agree by construction rather than by evidence.
Versus peersLatest session
Peer set · 5 names
SymbolRelationshipPriceSession
VRTXPeer$526.19+0.73%
REGNPeer$788.04-1.00%
ARGXPeer$959.49-0.28%
RVMDPeer$204.97+2.56%
ALNYPeer$255.96+2.55%
The mapped peer set and how each traded in the latest session. A peer moving with this name says the move is the sector's; one moving against it says the move is this company's.
Time machineHistory from 2023-06-01
Signal
Every backward window is positive.

That is the definition of a stock that has already worked, and it says nothing about the next window. What it does tell you is what a drawdown would be measured against.

Historical retrospective. Context, not a forecast.
Macro driversRolling window
Next macro catalystIN 2 DAYS
Job Openings (JOLTS)
2026-09-29. A scheduled release that moves this stock independently of anything the company does.
Events · what moves this stockSep 20, 2026
Initial jobless claimsLittle effect either way
Healthcare demand does not depend on hiring.
Typical for the Healthcare sector
report daytrading days before and after the report
On the day +0.1% · A week later +1.0% · Two weeks later +1.6% · Rose on 77 of 161 report days
Across the last 161 Initial jobless claims reports since Jun 8, 2023, NUVL moved +0.1% on average on the day and was 1.6% higher two weeks later. The S&P 500 moved 0.0% on those days.
Consumer sentiment (UMich) is due in 12 days.
Consumer sentiment (UMich)Little effect either way
Little direct link.
Typical for the Healthcare sector
report daytrading days before and after the report
On the day +0.3% · A week later -0.1% · Two weeks later +1.7% · Rose on 20 of 37 report days
Across the last 37 Consumer sentiment (UMich) reports since Jun 26, 2023, NUVL moved +0.3% on average on the day and was 1.7% higher two weeks later. The S&P 500 moved 0.0% on those days.
Core PCE (the Fed's gauge) is due in 3 days.
Core PCE (the Fed's gauge)Little effect either way
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
report daytrading days before and after the report
On the day -0.1% · A week later +0.3% · Two weeks later +1.9% · Rose on 18 of 37 report days
Across the last 37 Core PCE (the Fed's gauge) reports since Jun 28, 2023, NUVL moved -0.1% on average on the day and was 1.9% higher two weeks later. The S&P 500 moved +0.3% on those days.
FOMC decisionLittle effect either way
Healthcare demand does not depend on rates.
Typical for the Healthcare sector
report daytrading days before and after the report
On the day -0.4% · A week later +0.2% · Two weeks later +2.6% · Rose on 17 of 37 report days
Across the last 37 FOMC decision reports since Jul 1, 2023, NUVL moved -0.4% on average on the day and was 2.6% higher two weeks later. The S&P 500 moved -0.1% on those days.
Housing startsLittle effect either way
Little direct link.
Typical for the Healthcare sector
report daytrading days before and after the report
On the day 0.0% · A week later +1.2% · Two weeks later +1.1% · Rose on 18 of 37 report days
Across the last 37 Housing starts reports since Jun 20, 2023, NUVL moved 0.0% on average on the day and was 1.1% higher two weeks later. The S&P 500 moved 0.0% on those days.
Industrial productionLittle effect either way
Healthcare does not track the business cycle.
Typical for the Healthcare sector
report daytrading days before and after the report
On the day +1.2% · A week later +1.3% · Two weeks later +0.8% · Rose on 19 of 37 report days
Across the last 37 Industrial production reports since Jun 15, 2023, NUVL moved +1.2% on average on the day and was 0.8% higher two weeks later. The S&P 500 moved +0.2% on those days.
Job openings (JOLTS) is due in 2 days.
Job openings (JOLTS)Little effect either way
Healthcare demand does not depend on hiring.
Typical for the Healthcare sector
report daytrading days before and after the report
On the day 0.0% · A week later +2.0% · Two weeks later +2.9% · Rose on 16 of 37 report days
Across the last 37 Job openings (JOLTS) reports since Jul 5, 2023, NUVL moved 0.0% on average on the day and was 2.9% higher two weeks later. The S&P 500 moved +0.1% on those days.
Jobs report (nonfarm payrolls) is due in 5 days.
Jobs report (nonfarm payrolls)Little effect either way
Healthcare demand does not depend on hiring.
Typical for the Healthcare sector
report daytrading days before and after the report
On the day -0.5% · A week later +1.4% · Two weeks later +2.6% · Rose on 15 of 37 report days
Across the last 37 Jobs report (nonfarm payrolls) reports since Jul 6, 2023, NUVL moved -0.5% on average on the day and was 2.6% higher two weeks later. The S&P 500 moved 0.0% on those days.
Customer momentum
Data unavailableCustomer momentum needs listed customers that disclose a revenue dependence on this company, and none is on file. The connections below are a different map: competitors and partners, most of them curated rather than filed.
Connections3 links · 1 confirmed
Direct connections · 3 edges
CompanyRelationSessionProvenance
IQV · Partnerpartner-1.69%Rumored · manual
AMZN · Suppliersupplier+0.12%Rumored · manual
PFE · Competitorcompetitor+0.92%Confirmed · manual
1 of 3 edges are named in a filing; the rest come from reporting we have not matched to one yet, and are labelled as such.
Suppliers, customers & competitors
Who depends on it
IQVPartnerpartner
What it depends on
AMZNSuppliersupplier
Named competitors
PFECompetitorcompetitor
Glossary · every term on this page
Survival
Altman Z

Bankruptcy-risk score. Above 3.0 is the safe band.

Piotroski F

Nine pass/fail health tests; 7 or more is strong.

Beneish M

Accrual and growth pattern screen. Clear below −2.22, watch to −1.78, elevated above; a year of very fast revenue growth lifts it by construction.

Merton DTD

Standard deviations of asset value between the company and its debt.

EDF

Default frequency calibrated on what actually happened to similar names.

Price & tape
RSI-14

Momentum gauge 0–100. Above 70 is overbought, below 30 oversold.

ATR

Average true range — the size of a typical day.

VWAP

20-day volume-weighted average price — the average paid over the last month; the page shows no intraday VWAP.

Supertrend

A trend-following stop line. A close through it flips the read.

Chandelier

A trailing stop set a few average ranges below the recent high.

Options & flow
Gamma / GEX

Dealer hedging pressure. Negative gamma amplifies moves both ways.

Call / put wall

The strikes with the heaviest open interest; they act as ceiling and floor.

Max pain

The strike where most options expire worthless.

13F · Form 4

Institutional filings, 45 days after quarter end. Insider trades, within two days.

Scoring
Composite signal

Independent factors scored and netted into one number.

Hit-rate

Share of past calls that resolved in the direction stated.

Brier score

Calibration measure. Lower means stated probabilities track reality.

HHI

Concentration 0–10,000. Above 2,500 means one segment carries the company.

EVT

Fits the tail rather than assuming a bell curve, so bad days are not understated.

Deep dive
Nuvalent Inc (NUVL) Stock Price & Signals · Deep dive · QTick